Society of Cardiovascular Computed Tomography (SCCT)


The integration of artificial intelligence (AI) into medicine has by far been the hottest topic at nearly all medical conferences for radiology, cardiology and several other subspecialties over the past two years. This has led to the creation of an organization AIMed to help spearhead collaboration and dissemination of information on AI developments to speed its adoption. 


Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy, even when all traces of the cancer appear to have gone. These findings are according to late-breaking results presented at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference, April 26-30 in Milan, Italy.

IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain and Telemis aimed at accelerating installation, optimizing service and improving clinical operations for proton therapy.

Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.


May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has developed technology to use radiation therapy in the heart (cardiac radio-ablation) and other forms of radiosurgery for cardiovascular disease. This technology signals the company's entry into cardiology with a first of its kind technology that could represent a pardigm shift in electrophysiology (EP) ablation procedures. 


Imaging Technology News (ITN) earned an Honorable Mention at the 2019 National Azbee Awards of Excellence in the Cross-Platform Package of the Year category for its coverage of the ITN editorial team’s visit to Central DuPage Hospital in Winfield, Ill.

When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast cancer and avoid unnecessary biopsies, according to a new study. The findings were presented at the American Roentgen Ray Society (ARRS) 2019 Annual Meeting, May 5-10 in Honolulu.

I miss the days when the difference between meaningful and meaningless was apparent; when the line separating relevant and irrelevant was easily drawn. I miss when truth mattered. When the old joke was just a joke: “How do you know when (the person, often a politician) is lying. His lips are moving.”

Today the joke is on us. All of us.

May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing an innovative procedure that may provide hope in the fight against Alzheimer’s disease.

Subscribe Now